Across TCGA pan-cancer cohorts, PIK3AP1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated PIK3AP1 data layer compared with 21 for mass-spec protein and 6 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher PIK3AP1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated PIK3AP1 expression acts as an unfavorable survival marker, although some lineages such as HNSC and LSCC show a favorable association.
COAD, LUAD, and GBM are the cancer types where PIK3AP1 mass-spec protein most reproducibly stratifies survival.